All You Need to Know About Encompass Health (EHC) Rating Upgrade to Buy
Encompass Health (EHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Encompass Health (EHC) is a Top-Ranked Growth Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
EHC Opens New Lake Worth Rehab Hospital to Meet Rising Demand
Encompass Health expands its Florida presence with a new Lake Worth rehab hospital, adding 50 beds and advanced therapy services to meet rising demand.
Here's Why Encompass Health (EHC) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Encompass Health (EHC) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
EHC Expands in Tennessee Via New JV Facility With Vanderbilt Health
Encompass Health teams up with Vanderbilt Health to open a new 40-bed inpatient rehabilitation hospital in Tennessee, targeting a 2028 launch.
Why Encompass Health (EHC) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Encompass Health Shares Down 8% Despite Q3 Earnings & Revenue Beat
EHC shares fall 8% after Q3 results, as higher costs offset revenue gains, bed expansions and an upbeat 2025 outlook.
Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Compared to Estimates, Encompass Health (EHC) Q3 Earnings: A Look at Key Metrics
The headline numbers for Encompass Health (EHC) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Encompass Health Corporation (EHC) Q3 2025 Earnings Call Transcript
Encompass Health Corporation ( EHC ) Q3 2025 Earnings Call October 30, 2025 10:00 AM EDT Company Participants Mark Miller - Senior Vice President of Investor Relations & Strategic Planning Mark Tarr - CEO, President & Director Douglas Coltharp - Executive VP & CFO Patrick Tuer - EVP & Chief Operating Officer Conference Call Participants Joanna Gajuk - BofA Securities, Research Division Pito Chickering - Deutsche Bank AG, Research Division Ann Hynes - Mizuho Securities USA LLC, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Benjamin Mayo - Leerink Partners LLC, Research Division Andrew Mok - Barclays Bank PLC, Research Division Albert Rice - UBS Investment Bank, Research Division Brian Tanquilut - Jefferies LLC, Research Division Jared Haase - William Blair & Company L.L.C., Research Division Raj Kumar - Stephens Inc., Research Division Presentation Operator Good morning, everyone, and welcome to Encompass Health's Third Quarter 2025 Earnings Conference Call.
Encompass Health (EHC) Tops Q3 Earnings and Revenue Estimates
Encompass Health (EHC) came out with quarterly earnings of $1.23 per share, beating the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $1.03 per share a year ago.
